Comparison of oral anticoagulation use and adherence among Medicare beneficiaries enrolled in stand-alone prescription drug plans vs Medicare Advantage prescription drug plans

BACKGROUND: For atrial fibrillation (AF) patients, oral anticoagulants (OACs) can reduce the risk of stroke by 60%; however, nearly 50% of patients recommended to receive OACs do not receive therapy. Integrated insurers that cover pharmacy and medical benefits may be incentivized to improve OAC use...

Descripción completa

Detalles Bibliográficos
Autores principales: Newman, Terri Victoria, Gabriel, Nico, Liang, Qinfeng, Drake, Coleman, El Khoudary, Samar R, Good, Chester B, Gellad, Walid F, Hernandez, Inmaculada
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Academy of Managed Care Pharmacy 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856760/
https://www.ncbi.nlm.nih.gov/pubmed/35098746
http://dx.doi.org/10.18553/jmcp.2022.28.2.266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8856760/
https://www.ncbi.nlm.nih.gov/pubmed/35098746
http://dx.doi.org/10.18553/jmcp.2022.28.2.266

Ejemplares similares